3 Einträge gefunden

1. Secukinumab is effective in treatment of moderate-to-severe plaque psoriasis: real-life effectiveness and safety from the PROSPECT study

   1. Thaçi, D
   2. Körber, A
   3. von Kiedrowski, R
   4. Bachhuber, T
   5. Melzer, N
   6. Kasparek, T
   7. Duetting, E

   2020 - Forschungsinformationssystem des UKE
2. Secukinumab treatment of moderate to severe plaque psoriasis in routine clinical care: real-life data of prior and concomitant use of psoriasis treatments from the PROSPECT study

   1. Körber, A
   2. Thaçi, D
   3. von Kiedrowski, R
   4. Bachhuber, T
   5. Melzer, N
   6. Kasparek, T
   7. Kraehn-Senftleben, G

   2018 - Forschungsinformationssystem des UKE
3. Secukinumab is superior to fumaric acid esters in treating patients with moderate-to-severe plaque psoriasis who are naive to systemic Treatments: results from the randomized controlled PRIME trial

   1. Sticherling, M
   2. Mrowietz, U
   3. Augustin, M
   4. Thaçi, D
   5. Melzer, N
   6. Hentschke, C
   7. Kneidl, J

   2017 - Forschungsinformationssystem des UKE